Evaluation of the Effect of a Novel beta 3-Adrenergic Agonist on Choroidal Vascularity

Creative Commons License

TOPCUOĞLU M., Aslan F.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol.62, no.9, 2021 (SCI-Expanded)

  • Publication Type: Article / Article
  • Volume: 62 Issue: 9
  • Publication Date: 2021
  • Doi Number: 10.1167/iovs.62.9.17
  • Journal Name: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Keywords: bladder overactivity, choroid, choroidal vascularity index, mirabegron, OCT, retina, beta(3)-adrenoceptor agonist, BETA(3)-ADRENOCEPTOR AGONISTS, OVERACTIVE BLADDER, HEALTHY EYES, DOUBLE-BLIND, RECEPTORS, THICKNESS, POPULATION, SOLABEGRON, RELAXATION, MIRABEGRON
  • Open Archive Collection: AVESIS Open Access Collection
  • Akdeniz University Affiliated: No

Abstract

PURPOSE. To determine the effect of the new beta(3)-agonist (mirabegron), which is used for overactive bladder (OAB) treatment, on central retinal thickness (CRT) and choroidal vascularity.